ICL in 2025: Prices Recovered, but the Real Test Moved to Cash and 2030

Getting to Know the Company

ICL is often screened as a large fertilizer producer. That is only partly right. In practice, it is a global platform built around three mineral value chains, bromine, potash and phosphate, alongside specialty crop nutrition and food ingredients. In 2025 the company sold into more than 100 countries, employed 13,007 people, generated 56% of total sales from production activity outside Israel, and had no single customer accounting for more than 10% of sales. That matters because the company is operationally diversified, but its economics still rest on a small number of highly cyclical profit engines.

2025 can also be misread very quickly. On the surface, sales rose 5% to $7.153 billion, adjusted EBITDA was broadly stable at $1.488 billion, and potash prices recovered. It is easy to stop there and call it a clean recovery year. That is incomplete.

What is working now is fairly clear: Potash operating income rose to $298 million from $250 million, Growing Solutions kept expanding, and the balance sheet remains solid, with covenant net debt to EBITDA at 1.35, EBITDA to net interest expense at 15.48, and BBB- stable ratings from both S&P and Fitch. What blocks a cleaner thesis is something else entirely: reported operating income fell 25% to $580 million, net income attributable to shareholders fell 44% to $226 million, and operating cash flow dropped by $412 million to $1.056 billion.

So the right question for ICL in 2025 is not whether prices improved, but whether that improvement already became durable shareholder economics. The answer is only partial. The assets are strong, liquidity is solid, and there is no near-term balance-sheet panic. But 2026 is already a proof year: the company needs to show that better commodity prices can also turn into cleaner reported earnings, better cash generation, and a more credible read-through to 2030.

The Economic Map

The key point in this map is that ICL talks about a shift toward specialties, but nearly 69% of segment EBITDA still comes from Potash and Phosphate Solutions. Even after acquisitions, innovation and growth initiatives, the economic center of gravity still sits in the mineral base, its cost structure and the commodity environment.

Events and Triggers

Potash pricing recovered, but that did not solve everything

First trigger: Potash pricing clearly improved in 2025. Granular potash in Brazil averaged $348 per tonne versus $299 in 2024, Northwest Europe was €355 per tonne versus €349, and Southeast Asia was $348 versus $294. Mid-year contracts with India and China were signed at $349 and $346 per tonne. That is the main reason Potash operating income stepped up so meaningfully.

But even here the picture is not fully clean. Production fell to 4.377 million tonnes from 4.502 million, total sales volume fell to 4.320 million tonnes from 4.556 million, and closing inventory rose to 286 thousand tonnes from 229 thousand. In other words, price did more of the work than volume. That matters because in 2026 the market will watch not only whether pricing holds, but whether volumes normalize after operational issues and weather-related loading disruptions at Ashdod Port.

In phosphate, prices rose, but sulphur rose much more

Second trigger: Phosphate can look good on a quick read. The company describes average phosphate fertilizer benchmark prices as up 20% year over year. DAP India averaged $720 per tonne versus $587, and TSP Brazil averaged $555 versus $465. The real story, though, sits on the input side. Average sulphur prices rose to $286 per tonne from $100 in 2024, a 186% increase.

That is exactly why Phosphate Solutions sales rose by $118 million, while operating income fell by $16 million. The market can easily see better selling prices and assume margin expansion followed. That would be wrong. What actually happened is that the company sold into a better pricing environment while a large part of the benefit was absorbed by raw material inflation.

The agreement with the State buys clarity, not the future concession

Third trigger: In January 2026 ICL signed a detailed and binding agreement with the State regarding the Dead Sea concession assets. The agreement sets consideration of $2.54 billion for the concession assets, plus actual salt-harvesting investments made from January 1, 2025, estimated in the filing at hundreds of millions of dollars. Ninety-five percent is scheduled for payment on April 1, 2030, with the remaining 5% on September 1, 2030, subject to adjustments.

This is meaningful because it reduces uncertainty around asset value and payment timing, and it also establishes operating continuity arrangements for downstream industries through March 31, 2035. But two different questions need to be separated. Asset value at concession expiry is now clearer. Winning the future concession is not. The next concession is still expected to be allocated through a competitive process, and the company itself says it intends to participate only if the terms are economically viable and support a stable regulatory environment.

Bartek and the CFO transition highlight the main 2026 themes

Fourth trigger: In January 2026 the company acquired 49.9% of Bartek Ingredients, together with preferred debt, for total consideration of approximately $90 million. The filing says ICL holds a substantive call option on the remaining shares, so Bartek will be consolidated. Strategically, this fits the move toward specialty food ingredients, but in scale terms it is still small relative to the heavy economics of the Dead Sea, potash and phosphate.

Fifth trigger: The CFO will change in June 2026. That is not a thesis by itself, but for a company entering a period shaped by regulatory transition, targeted M&A and capital allocation around 2030, finance leadership matters more than usual.

Efficiency, Profitability and Competition

The most important number in 2025 is not higher sales. It is the gap between what price gave and what the cost base took away. At the company level, management attributes a positive $298 million operating income effect to price. Raw materials took away $129 million, exchange rates took away $43 million, and operating and other expenses took away $132 million. In other words, most of what the commodity environment gave back, the cost structure absorbed.

Industrial Products: trade protection helped, demand did not really recover

In Industrial Products, sales rose slightly to $1.254 billion, but operating income slipped to $220 million. Demand for flame retardants stayed weak, especially in construction-related end markets and in China and Europe. On the other hand, the EU and the US imposed 63% and 200% duties on TCPP imports from China, which supported pricing and volume. This is a good example of a segment that did not benefit from a broad organic recovery, but rather from a combination of defensive trade measures and selective product strength.

Potash: the segment that is truly working, but quality still needs testing

Potash is clearly the cleanest engine in the portfolio right now. Operating income rose to $298 million from $250 million, and EBITDA increased to $552 million from $492 million. But even here it is important not to confuse a good year with a fully clean one. Price contributed $102 million to operating income, while quantity subtracted $22 million. That means the recovery depended more on pricing than on broad volume growth. In addition, energy costs were hurt by higher water fees, and other costs rose due to maintenance, operations and royalties.

Phosphate Solutions: the segment that best captures the price versus quality gap

This may be the segment that tells the 2025 story most clearly. Sales rose to $2.333 billion, but operating income fell to $342 million. The main culprit was sulphur. If the reader is asking what can be missed on first glance, this is the answer: phosphate prices improved, but the quality of that recovery was eroded by input costs.

Growing Solutions: growth is real, but margins are still modest

In Growing Solutions, sales rose to $2.063 billion and operating income to $135 million. There is better pricing here, progress in specialty agriculture, and support from the 2024 acquisitions, but the EBITDA margin is still only 10%. That means the strategic direction is valid, but by the end of 2025 it is not yet large enough to redefine the group on its own.

Segment Dynamics

The real test of ICL’s specialty narrative is not how often the word appears in investor materials, but how much EBITDA it actually produces relative to the legacy engines. Inside Phosphate Solutions, the 2025 internal split is sharp: phosphate specialties generated $1.332 billion of sales and $206 million of EBITDA, while phosphate commodities generated $1.001 billion of sales and $322 million of EBITDA. In other words, the more cyclical commodity piece still produces more EBITDA than the more specialized piece inside the same segment.

This is not an argument against the strategy. It is a reminder about the actual economic order inside the company. The transformation exists, but shareholders still depend heavily on the execution quality of the mineral base and on the commodity cycle.

Cash Flow, Debt and Capital Structure

This is where the automatic “stable EBITDA means everything is fine” reading needs to stop. For financing flexibility, the right frame here is an all-in cash view, after the real uses of cash disclosed in the filings, not a normalized earnings-power view.

The first warning sign is the gap between presentation language and cash statement language. The investor presentation shows free cash flow of $664 million, but defines it as EBITDA minus CAPEX. In the same footnote, the company says that in its other presentations it normally uses cash flow from operations minus CAPEX, and that for 2025 this measure was only $236 million. That is the heart of the issue. EBITDA minus CAPEX and cash actually left over are not the same thing.

The financial statements sharpen the point. Operating cash flow fell to $1.056 billion from $1.468 billion, mainly due to changes in operating assets and liabilities and higher taxes paid. Purchases of property, plant and equipment and intangible assets were $824 million. Dividends paid were $224 million to shareholders plus $64 million to non-controlling interests. Interest paid was $117 million. So even before loading the bridge with gross debt repayments, acquisitions and deposit changes, the cash picture is already much tighter than the headline suggests.

At the same time, it is important not to overshoot in the other direction. This is not a liquidity stress case. At year-end the company had $496 million of cash, cash equivalents, short-term investments and deposits. The presentation points to $1.6 billion of available liquidity including undrawn facilities. Covenant net debt to EBITDA was 1.35, EBITDA to net interest expense was 15.48, equity stood at $5.983 billion, and both S&P and Fitch kept the ratings at BBB- with a stable outlook.

The maturity structure also does not look like a near-term wall. The RCF was extended to April 2030, the new securitization facility runs to December 2030, and the company already repaid a $46 million private placement bond in January 2026. So the right reading is not “debt stress”, but cash conversion that is weaker than the EBITDA headline implies.

Outlook

First finding: 2025 proved that ICL can still benefit from better pricing, but it did not yet prove that this pricing recovery can reliably become cleaner cash.

Second finding: The add-back gap became very large. Reported operating income was $580 million, while adjusted operating income was $873 million. The $293 million gap includes $131 million of impairments and write-offs, $80 million from legal proceedings, disputes and other settlements, $54 million tied to the security situation in Israel, and $28 million of early retirement provisions. That does not automatically make adjusted earnings useless, but it does mean the market should be more demanding about the quality of reported earnings.

Third finding: 2030 is already embedded in the accounting. The external auditor identified the useful lives of Dead Sea Works concession-related long-lived assets as a critical audit matter, because the financial statements assume it is more likely than not that the company will continue operating those assets beyond March 2030 through a new concession. So 2030 is not just a strategic issue. It is already part of the accounting architecture through depreciation and asset lives.

Fourth finding: The agreement with the State reduces uncertainty around value and payment timing, but it still does not give investors a simple model for post-2030 profitability. Even the presentation itself says Dead Sea operations are not a separate segment, so its post-2030 EBITDA ranges are internal estimates rather than a segment base that investors can track in the accounts.

2026 is a proof year, not a victory year

If the coming year needs a label, it is probably a proof year. The company no longer needs to prove that it owns strong core assets. That is already clear. It needs to prove three other things: that potash will not depend only on price and can also normalize in volume, that phosphate can absorb sulphur and raw material costs without losing most of the pricing upside, and that operating cash flow can start supporting the story instead of lagging it.

What has to happen in the next 2 to 4 quarters

The first checkpoint is cash. Without a clear improvement in operating cash flow and actual cash metrics, even stable EBITDA will not be enough to convince the market that 2025 was more than a pricing cycle rebound.

The second checkpoint is phosphate margin quality. The market will need to see whether the company can pass through more of the sulphur burden, or alternatively benefit from some normalization in inputs.

The third checkpoint is 2030. A full concession outcome is not needed immediately, but investors do need more progress on the framework, the regulatory language and the company’s ability to show that the value created around the Dead Sea can remain accessible to shareholders rather than only recognized at the asset level.

The fourth checkpoint is portfolio quality. Bartek can strengthen the food-specialties direction, but the real question is not whether another acquisition happened. It is whether the addition truly improves the earnings mix, or just adds another integration layer to a business still dominated by large mineral engines.

Risks

Commodity prices are not the whole story, but they remain the first risk

Potash and phosphate still drive a large part of group economics. If potash weakens again, or if phosphate prices stay firm while sulphur remains elevated, the company can quickly end up back in a situation where the price list looks better than the underlying economics.

The State relationship remains a core risk

In 2025 the company already recorded a significant impact from the Supreme Court ruling on water extraction fees, including a $94 million provision, of which $80 million related to prior years. In addition, other expenses and payments to the State rose, with total Government Takes reaching $442 million versus $364 million in 2024. That is a reminder that in ICL’s case the State is not just a regulator. It is also a major economic counterparty.

FX, geography and weak industrial demand are still pressure points

The company explicitly says that shekel appreciation hurt profitability in 2025, partly offset by hedging and Brazilian real depreciation. In Industrial Products, demand in China and Europe remained weak. So even if some commodity markets are recovering, not all of ICL’s end markets are moving in the same direction.

The real concentration is not a single customer, but a combination of assets, regulation and inputs

ICL does not depend on a single customer for more than 10% of sales, and that is a real strength. But customer diversification does not solve the company’s deeper economic concentration. The concentration here sits in key mineral assets, the regulatory framework around the Dead Sea, fertilizer cycles and a handful of critical inputs.

Short Interest View

Short-interest data does not show an aggressive bearish crowd around the stock. As of March 27, 2026, short float stood at 0.52% and SIR at 1.24. That is somewhat above the sector averages of 0.34% for short float and 0.916 for SIR, but still very low in absolute terms.

The practical implication is that the near-term market debate around ICL is probably not being expressed through a heavy short base. This is a stock the market is more likely to read through commodities, cash flow and 2030 than through a squeeze or a crowded position.

---

Conclusions

ICL ended 2025 with a real recovery in potash and phosphate pricing, a stronger Potash segment, and a balance sheet that does not point to near-term stress. The main bottleneck moved elsewhere: the quality of conversion from recovery into reported earnings and cash. That is what the market is likely to measure over the short to medium term, together with every step that either strengthens or weakens real clarity around 2030.

Current thesis: 2025 showed a real pricing recovery, but 2026 still needs to prove that this recovery can show up in cash, reported earnings and a cleaner post-2030 read.

What changed: The center of the story moved away from commodity pricing alone toward a three-part test, earnings quality, cash quality and the company’s ability to turn the State agreement into value that is actually accessible to shareholders.

Counter-thesis: It is possible that the combination of potash recovery, the 2026 China contract, specialty reinforcement through Bartek and a strong enough balance sheet will make current concerns about cash quality and concession risk look overstated.

What could change the market reading in the short to medium term: A visible improvement in operating cash flow, potash prices holding at current levels, relief on sulphur costs, and any regulatory step that gives the market a clearer framework for reading 2030.

Why this matters: ICL is not simply an EBITDA story. It is a company where investors need to separate operating value, accounting value and the cash that actually remains with shareholders.

What must happen next: Over the next 2 to 4 quarters the company needs to show that potash volumes improve, phosphate margins are not compressed again by inputs, operating cash flow recovers, and visibility around 2030 keeps improving without damaging the economics of the business.